Recommendations for the cytogenetic management of chronic lymphoid leukemia established by the French Group of Hematological Cytogenetics (GFCH);Recommandations pour la prise en charge cytogénétique d'une leucémie lymphoïde chronique établies par le Groupe Français de Cytogénétique Hématologique (GFCH)

Pathologie Biologie

Volumn 52, Issue 5, 2004, Pages 254-256

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; PATIENT CARE; PRACTICE GUIDELINE; SHORT SURVEY; TREATMENT PLANNING;

CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CYTOGENETICS; FRANCE; HEMATOLOGY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 3042613904     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.04.008     Document Type: Short Survey

References (7)

1. Matutes E., Owusu-Ankomah K., Morilla R., Garcia Marco J., Houlihan A., Que T.H., et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 8:(10):1994 Oct;1640-1645
2. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med. 323:(11):1990 Sep 13;720-724
3. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 343:(26):2000 Dec 28;1910-1916
4. Stilgenbauer S., Bullinger L., Lichter P., Dohner H. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia. 16:(6):2002 Jun;993-1007. Review
5. Lin K., Sherrington P.D., Dennis M., Matrai Z., Cawley J.C., Pettitt A.R. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood. 100:(4):2002 Aug 15;1404-1409
6. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 100:(4):2002 Aug 15;1177-1184
7. Krober A., Seiler T., Benner A., Bullinger L., Bruckle E., Lichter P., et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 100:(4):2002 Aug 15;1410-1416